Main |
Browse Volumes |
Forthcoming Volumes |
Annals PrePrints |
Annals Extra |
E-mail Alerts |
Subscriptions & Orders |
New Proposals |
Author Guidelines |
About Annals |
Help |
 |
|
|
|
|
|
Oxidative Stress and Redox-Active Iron in Alzheimer's Disease
KAZUHIRO HONDA,
GEMMA CASADESUS,
ROBERT B. PETERSEN,
GEORGE PERRY AND
MARK A. SMITH
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA
Address for correspondence: Mark A. Smith, Ph.D., Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106. Voice: 216-368-3670; fax: 216-368-8964. mark.smith{at}case.edu
Ann. N.Y. Acad. Sci. 1012: 179-182 (2004).
Many lines of evidence indicate that oxidative stress is one of the earliest events in the genesis of Alzheimer's disease (AD). Iron is a transition metal capable of generating hydroxyl radicals, the most potent reactive oxygen species. Consequently, a disruption in the metabolism of iron has been postulated to have a role in the pathogenesis of AD. Indeed, both senile plaques and neurofibrillary tangles, the major pathological landmarks of AD, as well as neurons in the earliest stages of the disease, show elevated iron deposition. However, it is clear that the iron bound to lesion-associated proteins such as amyloid-ß and tau plays only a minor, late role in the disease, with the RNA-associated iron found in the neuronal cytoplasm occurring early and being of paramount importance. In this regard, it is probably not surprising that there is significant oxidation of cytoplasmic RNA among the populations of neurons vulnerable to AD. In this review, we consider the role of iron-induced oxidative stress as a key event in AD pathophysiology.
Key Words: Alzheimer's disease • amyloid-ß • iron • mitochondria • redox • RNA
This article has been cited by other articles:
|
|
|
|
 
N. Boddaert, K. H. Le Quan Sang, A. Rotig, A. Leroy-Willig, S. Gallet, F. Brunelle, D. Sidi, J.-C. Thalabard, A. Munnich, and Z. I. Cabantchik
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Blood,
July 1, 2007;
110(1):
401 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Brewer
Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer's Disease
Experimental Biology and Medicine,
February 1, 2007;
232(2):
323 - 335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S Parihar and G. J. Brewer
Mitoenergetic failure in Alzheimer disease
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C8 - C23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Chicco and G. C. Sparagna
Role of cardiolipin alterations in mitochondrial dysfunction and disease
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C33 - C44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. I. Moreira, K. Honda, X. Zhu, A. Nunomura, G. Casadesus, M. A. Smith, and G. Perry
Brain and brawn: Parallels in oxidative strength
Neurology,
January 24, 2006;
66(1_suppl_1):
S97 - S101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
